8/1/2013 9:50:32 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
NEW YORK, July 31, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced its results for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by